Home » Novacyt Nabs CE Mark for COVID-19 Diagnostic
Novacyt Nabs CE Mark for COVID-19 Diagnostic
Novacyt has been given approval to market its novel coronavirus diagnostic test in Europe for clinical detection of the 2019 strain of the virus.
The France-based biotech company said it believes its COVID-19 test is the first one to receive CE Mark certification.
Novacyt has already received orders for 288,000 tests and previously launched a research-use-only test for the novel coronavirus on January 31.
Upcoming Events
-
07May
-
14May
-
23May
-
30May
-
20Jun
-
21Oct